112 related articles for article (PubMed ID: 1667986)
41. Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels.
Slodkowska J; Szturmowicz M; Rudzinski P; Giedronowicz D; Sakowicz A; Androsiuk W; Zakrzewska-Rowinska E
Eur J Cancer Prev; 1998 Feb; 7(1):51-60. PubMed ID: 9511851
[TBL] [Abstract][Full Text] [Related]
42. [Determination of lymphocyte subpopulations, defined with monoclonal antibodies, in patients with iron deficiency anemia].
Luraschi A; Borgotti P; Gioria A; Fedeli P
Minerva Med; 1991 Sep; 82(9):557-63. PubMed ID: 1945004
[TBL] [Abstract][Full Text] [Related]
43. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
44. [Influence of HPD on immunological functions in patients with nasopharyngeal carcinoma treated by radiotherapy].
Xia Y; Zhang E; Hu Y
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(3):168-70. PubMed ID: 9639718
[TBL] [Abstract][Full Text] [Related]
45. [Measurement of carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific enolase in the bronchoalveolar lavage fluid in patients with peripheral lung cancer].
Fujii M; Kiura K; Kamei H; Segawa Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Apr; 27(4):452-5. PubMed ID: 2552209
[TBL] [Abstract][Full Text] [Related]
46. Relationship between serum carcinoembryonic antigen level and T status in non-small cell lung cancer.
Tomita M; Matsuzaki Y; Shimizu T; Hara M; Ayabe T; Onitsuka T
Anticancer Res; 2006; 26(5B):3845-8. PubMed ID: 17094411
[TBL] [Abstract][Full Text] [Related]
47. Regional and systemic CD4 and CD8 subsets in bronchogenic carcinoma.
Liss HP; Baumann MA; Paul CC; Payne CB
Neth J Med; 1991 Dec; 39(5-6):333-7. PubMed ID: 1687075
[TBL] [Abstract][Full Text] [Related]
48. Complementary reactivities of anti-carcinoembryonic antigen and antitumor-associated glycoprotein 72 monoclonal antibodies in lung carcinomas.
Battista P; Muraro R; Mammarella S; Curia MC; Colasante A; Rosini S; Lesti G; Sacco R; French D; Frati L
Cancer Res; 1990 Nov; 50(21):6987-94. PubMed ID: 1698547
[TBL] [Abstract][Full Text] [Related]
49. [Cytotoxicity of lymphocytes against autologous cultured primary lung cancer cells in relation to histological type and clinical stage].
Kimura H; Yamaguchi Y; Kadoyama C; Matsumoto A
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2175-81. PubMed ID: 3013100
[TBL] [Abstract][Full Text] [Related]
50. [T-lymphocyte subsets in peripheral blood and pleural effusion in tuberculous pleurisy and carcinomatous pleurisy: analysis by monoclonal antibodies].
He Q
Zhonghua Jie He He Hu Xi Za Zhi; 1989 Apr; 12(2):96-8, 127. PubMed ID: 2791132
[TBL] [Abstract][Full Text] [Related]
51. [Diagnostic application of detecting AgNOR in peripheral blood T lymphocyte in patients with esophageal carcinoma].
Wang JY; Rong TH; Liang YR; Long H; Chen QL; Ma GW
Ai Zheng; 2004 May; 23(5):577-80. PubMed ID: 15142458
[TBL] [Abstract][Full Text] [Related]
52. [Carcinoembryonic antigen (CEA) in the blood serum of patients with bronchogenic carcinoma and selected diseases of the respiratory tract].
Szklarz E; Gawlikowski W
Pneumonol Pol; 1989 Apr; 57(4):217-21. PubMed ID: 2628950
[TBL] [Abstract][Full Text] [Related]
53. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck.
Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL
Clin Cancer Res; 2004 Jun; 10(11):3755-62. PubMed ID: 15173082
[TBL] [Abstract][Full Text] [Related]
54. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension.
Okada M; Sakamoto T; Nishio W; Uchino K; Tsubota N
Cancer; 2003 Aug; 98(3):535-41. PubMed ID: 12879471
[TBL] [Abstract][Full Text] [Related]
55. Prognostic determinants for lung cancer patients with preoperative high serum carcinoembryonic antigen levels.
Tomita M; Matsuzaki Y; Shimizu T; Hara M; Ayabe T; Onitsuka T
Thorac Cardiovasc Surg; 2005 Oct; 53(5):300-4. PubMed ID: 16208617
[TBL] [Abstract][Full Text] [Related]
56. Lung carcinoma: analysis of T helper type 1 and 2 cells and T cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry.
Ito N; Nakamura H; Tanaka Y; Ohgi S
Cancer; 1999 Jun; 85(11):2359-67. PubMed ID: 10357406
[TBL] [Abstract][Full Text] [Related]
57. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
Robinson E; Haim N; Segal R; Veseley Z; Mekori T
Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
[TBL] [Abstract][Full Text] [Related]
58. Effect of dosage of anticancer agents during transcatheter arterial chemoembolization on T cell subsets in patients with hepatocellular carcinoma.
Lu W; Li YH; He XF; Chen Y; Zeng QL; Qiu YR
Di Yi Jun Yi Da Xue Xue Bao; 2002 Jun; 22(6):524-6. PubMed ID: 12297475
[TBL] [Abstract][Full Text] [Related]
59. [Tumor markers--personal experience. A case report of primary lung cancer with interesting production of tumor markers].
Ariyoshi Y
Gan To Kagaku Ryoho; 1991 Aug; 18(10):1721-5. PubMed ID: 1872630
[TBL] [Abstract][Full Text] [Related]
60. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
